Trial Profile
The Effect of Liraglutide on Dietary Lipid Induced Insulin Resistance in Humans
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 04 Mar 2022
Price :
$35
*
At a glance
- Drugs Liraglutide (Primary)
- Indications Insulin resistance
- Focus Therapeutic Use
- 11 Mar 2020 Planned End Date changed from 1 May 2020 to 1 May 2021.
- 11 Mar 2020 Planned primary completion date changed from 1 Dec 2019 to 1 Dec 2020.
- 11 Apr 2019 Planned End Date changed from 1 Dec 2018 to 1 May 2020.